201 related articles for article (PubMed ID: 30418430)
1. Pretransplant Cancer in Kidney Recipients in Relation to Recurrent and De Novo Cancer Incidence Posttransplantation and Implications for Graft and Patient Survival.
Unterrainer C; Opelz G; Döhler B; Süsal C;
Transplantation; 2019 Mar; 103(3):581-587. PubMed ID: 30418430
[TBL] [Abstract][Full Text] [Related]
2. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
Kang W; Sampaio MS; Huang E; Bunnapradist S
Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
[TBL] [Abstract][Full Text] [Related]
3. Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.
Dahle DO; Grotmol T; Leivestad T; Hartmann A; Midtvedt K; Reisæter AV; Mjøen G; Pihlstrøm HK; Næss H; Holdaas H
Transplantation; 2017 Oct; 101(10):2599-2605. PubMed ID: 28207636
[TBL] [Abstract][Full Text] [Related]
4. Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.
Badve SV; Pascoe EM; Burke M; Clayton PA; Campbell SB; Hawley CM; Lim WH; McDonald SP; Wong G; Johnson DW
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1845-1855. PubMed ID: 27445164
[TBL] [Abstract][Full Text] [Related]
5. High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer.
Hellström V; Lorant T; Döhler B; Tufveson G; Enblad G
Transplantation; 2017 Jun; 101(6):1295-1302. PubMed ID: 27163539
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.
Alhamad T; Brennan DC; Brifkani Z; Xiao H; Schnitzler MA; Dharnidharka VR; Axelrod D; Segev DL; Lentine KL
Transplantation; 2016 May; 100(5):1086-93. PubMed ID: 26950718
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.
Heldal K; Hartmann A; Leivestad T; Svendsen MV; Foss A; Lien B; Midtvedt K
Transplantation; 2009 Apr; 87(7):1045-51. PubMed ID: 19352126
[TBL] [Abstract][Full Text] [Related]
8. Avoiding delays in time to renal transplantation: Pretransplant thyroid malignancy does not affect patient or graft survival after renal transplantation.
Delman AM; Turner KM; Ammann AM; Tang A; Steward D; Holm TM
Surgery; 2022 Jan; 171(1):220-226. PubMed ID: 34303544
[TBL] [Abstract][Full Text] [Related]
9. A Single-Center Assessment of Delayed Graft Function in Recipients of Simultaneous Liver and Kidney Transplant.
Aziz F; Gardezi A; Muth B; Blazel J; Garg N; Mohammed M; Mezrich J; Djamali A; Mandelbrot D; Parajuli S
Prog Transplant; 2020 Dec; 30(4):342-348. PubMed ID: 32930044
[TBL] [Abstract][Full Text] [Related]
10. Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
Lam NN; Garg AX; Knoll GA; Kim SJ; Lentine KL; McArthur E; Naylor KL; Bota SE; Sood MM
Am J Nephrol; 2017; 46(4):343-354. PubMed ID: 29024935
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Kidney Transplantation Abroad: A Single-Center Canadian Cohort Study.
Quach K; Sultan H; Li Y; Famure O; Kim SJ
Prog Transplant; 2016 Mar; 26(1):5-12. PubMed ID: 27136244
[TBL] [Abstract][Full Text] [Related]
12. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes.
Tremblay S; Kaiser TE; Alloway RR; Woodle ES; Diwan TS
Prog Transplant; 2016 Jun; 26(2):183-90. PubMed ID: 27207408
[TBL] [Abstract][Full Text] [Related]
13. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients.
Streja E; Molnar MZ; Kovesdy CP; Bunnapradist S; Jing J; Nissenson AR; Mucsi I; Danovitch GM; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1463-73. PubMed ID: 21415312
[TBL] [Abstract][Full Text] [Related]
14. Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients.
Molnar MZ; Huang E; Hoshino J; Krishnan M; Nissenson AR; Kovesdy CP; Kalantar-Zadeh K
Diabetes Care; 2011 Dec; 34(12):2536-41. PubMed ID: 21994430
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
Opelz G; Unterrainer C; Süsal C; Döhler B
Nephrol Dial Transplant; 2016 Aug; 31(8):1360-7. PubMed ID: 27190384
[TBL] [Abstract][Full Text] [Related]
16. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
17. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of malignant melanoma in kidney transplant recipients
.
Di Bartolomeo S; Rolak S; Joachim E; Xu YG; Astor BC; Parajuli S
Clin Nephrol; 2019 Dec; 92(6):293-301. PubMed ID: 31549628
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
20. Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis.
Hart A; Pfeiffer RM; Morawski BM; Lynch CF; Zeng Y; Pawlish K; Hurley D; Yu KJ; Engels EA
Am J Transplant; 2023 Feb; 23(2):257-264. PubMed ID: 36804133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
